I

Iksuda Therapeutics

31 employees

Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Licencing

Antibody Drug Conjugate

Antibodies

Clinical

Cancer Treatment

Conjugation Chemistry

ADCs

Drug Discovery

ADC Stability

Cell Biology

PermaLink™

Chemistry

Antibody-Drug Conjugates

Cancer research

Therapeutics

Toxins

Bioconjugation

Preclinical

Drug Development

Biopharma

Organic Synthesis

Date founded

2007

Funding rounds raised

Total raised

$47M

from 5 investors over 5 rounds

I

Iksuda Therapeutics raised $47M on June 7, 2021

Investors: Premier Partners and Celltrion Inc.

I

Iksuda Therapeutics raised $1M on July 10, 2013

Investors: THE NORTH EAST TECHNOLOGY FUND L.P.

I

Iksuda Therapeutics raised $3.1M on June 21, 2012

Investors: IP Group plc

I

Iksuda Therapeutics raised $793K on October 9, 2010